M. Kanekiyo
Epidemiology · 2013–2021
A researcher in the Science corpus: 16 papers; trusts 5 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 224 citations into it; #1,937 of 2,148 by trust here, #475 by citations
- Molecular Biology — 110 citations into it
- Radiology, Nuclear Medicine and Imaging — 89 citations into it
- Computational Biology & Bioinformatics — 31 citations into it
Whom M. Kanekiyo trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Po-Ssu Huang
- S. Harrison
- F. Krammer
- J. Taubenberger
- Scott E. Boyken
- Nicholas C. Wu
- David Baker
- L. Mesin
Who trusts M. Kanekiyo overall
Papers from M. Kanekiyo's perspective
Ordered by how strongly the researchers M. Kanekiyo trusts endorse each paper. Same corpus, a different order for every researcher.
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. (Annual Review of Biochemistry)
- Structural and Functional Bases for Broad-Spectrum Neutralization of Avian and Human Influenza A Viruses (Nature Structural &Molecular Biology)
- Phaser crystallographic software
- Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. (Lancet. Infectious Diseases (Print))
- Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
- Accurate design of megadalton-scale two-component icosahedral protein complexes
- Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
- Self-Assembling Influenza Nanoparticle Vaccines Elicit Broadly Neutralizing H1N1 Antibodies
- Evaluating conformational free energies: The colony energy and its application to the problem of loop prediction
Their papers
- Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens (2020) — 147 citations
- Next-Generation Influenza Vaccines. (2020) — 38 citations
- Quadrivalent influenza nanoparticle vaccines induce broad protection (2021) — 258 citations
- A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies (2020) — 79 citations
- Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses (2020) — 50 citations
- Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines (2020) — 30 citations
- Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses (2019) — 271 citations
- New Vaccine Design and Delivery Technologies (2019) — 60 citations
- Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages (2018) — 122 citations
- Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens (2018) — 79 citations
- Quantifying B cells capable of producing broadly neutralizing antibodies against influenza serves as a metric to guide the development of a universal influenza vaccine (2016)
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection (2015) — 672 citations
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera (2015) — 414 citations
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site (2015) — 346 citations
- Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages (2014) — 232 citations
- Self-Assembling Influenza Nanoparticle Vaccines Elicit Broadly Neutralizing H1N1 Antibodies (2013) — 823 citations